Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Tricida (TCDA – Research Report) and Replimune Group (REPL – Research Report). Tricida (TCDA) In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Hold rating on Tricida, with a price target of $8.00. The company's shares closed last Thursday at $9.95. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tricida-tcda-and-replimune-group-repl?utm_source=advfn.com&utm_medium=referral
Tricida (NASDAQ:TCDA)
Gráfico Histórico do Ativo
De Nov 2022 até Dez 2022 Click aqui para mais gráficos Tricida.
Tricida (NASDAQ:TCDA)
Gráfico Histórico do Ativo
De Dez 2021 até Dez 2022 Click aqui para mais gráficos Tricida.